Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS

Journal of Neurophysiology

Volumn 107, Issue 1, 2012, Pages 484-492

  Schuster, J E ^a   Fu, R ^a   Siddique, T ^a   Heckman, C J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Motoneuron excitability; Superoxide dismutase 1

Indexed keywords

RILUZOLE; SUPEROXIDE DISMUTASE;

ACTION POTENTIAL; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; HYPERPOLARIZATION; MALE; MEMBRANE STEADY POTENTIAL; MOTONEURON; MOUSE; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SLOW INWARD CURRENT; SPINE INJURY; TREATMENT DURATION; TREATMENT RESPONSE; UPREGULATION;

ACTION POTENTIALS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MOTOR NEURONS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; RILUZOLE;

EID: 84255182465     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00714.2011     Document Type: Article

References (52)

1. Amendola J, Durand J. Morphological differences between wild-type and transgenic superoxide dismutase 1 lumbar motoneurons in postnatal mice. J Comp Neurol 511: 329-341, 2008.
2. Baker RE, Ruijter JM. Chronic blockade of bioelectric activity in neonatal rat neocortex in vitro: physiological effects. Int JDev Neurosci 9: 321-329, 1991.
3. Bellingham MC. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17: 4-31, 2011.
4. + channels. Br J Pharmacol 140: 881-888, 2003.
5. Bennett DJ, Hultborn H, Fedirchuk B, Gorassini M. Synaptic activation of plateaus in hindlimb motoneurons of decerebrate cats. J Neurophysiol 80: 2023-2037, 1998.
6. Benoit E, Escande D. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflügers Arch 419: 603-609, 1991.
7. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330: 585-591, 1994.
8. Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59, 2006.
9. Bories C, Amendola J, Lamotte d'Incamps B, Durand J. Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25: 451-459, 2007.
10. Cao YJ, Dreixler JC, Couey JJ, Houamed KM. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur J Pharmacol 449: 47-54, 2002.
11. 2+ dependent. Neuroreport 6: 945-948, 1995.
12. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16: 4069-4079, 1996.
13. Del Negro CA, Morgado-Valle C, Hayes JA, Mackay DD, Pace RW, Crowder EA, Feldman JL. Sodium and calcium current-mediated pacemaker neurons and respiratory rhythm generation. J Neurosci 25: 446-453, 2005.
14. Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, Smith K, Cudkowicz ME, Ferrante RJ. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph Lateral Scler 10: 85-94, 2009.
15. Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6: 231-242, 2003.
16. Fishbein I, Segal M. Miniature synaptic currents become neurotoxic to chronically silenced neurons. Cereb Cortex 17: 1292-1306, 2007.
17. Harvey PJ, Li X, Li Y, Bennett DJ. 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 96: 1158-1170, 2006a.
18. Harvey PJ, Li X, Li Y, Bennett DJ. Endogenous monoamine receptor activation is essential for enabling persistent sodium currents and repetitive firing in rat spinal motoneurons. J Neurophysiol 96: 1171-1186, 2006b.
19. Harvey PJ, Li Y, Li X, Bennett DJ. Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats. J Neurophysiol 96: 1141-1157, 2006c.
20. Hebert T, Drapeau P, Pradier L, Dunn RJ. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45: 1055-1060, 1994.
21. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187: 761-772, 2009.
22. Koch H, Huh SE, Elsen FP, Carroll MS, Hodge RD, Bedogni F, Turner MS, Hevner RF, Ramirez JM. Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures. J Neurosci 30: 11678-11687, 2010.
23. Kononenko NI, Shao LR, Dudek FE. Riluzole-sensitive slowly inactivating sodium current in rat suprachiasmatic nucleus neurons. J Neurophysiol 91: 710-718, 2004.
24. Kriz J, Gowing G, Julien JP. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 53: 429-436, 2003.
25. Kumari KS, Satyanarayana B, Nagaswari A, Raj S. Development and validation of a novel stability-indicating LC method for the determination of riluzole in bulk drug and tablets. Chromatographia 69: 513-517, 2009.
26. Kuo JJ, Lee RH, Zhang L, Heckman CJ. Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones. J Physiol 574: 819-834, 2006.
27. + current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 563: 843-854, 2005.
28. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Powe L, Durrleman S, Delumeau JC, Meininger V. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 47: S242-S250, 1996.
29. Lee RH, Heckman CJ. Adjustable amplification of synaptic input in the dendrites of spinal motoneurons in vivo. J Neurosci 20: 6734-6740, 2000.
30. Li X, Murray K, Harvey PJ, Ballou EW, Bennett DJ. Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 97: 1236-1246, 2007.
31. Li Y, Bennett DJ. Persistent sodium and calcium currents cause plateau potentials in motoneurons of chronic spinal rats. J Neurophysiol 90: 857-869, 2003.
32. Murray KC, Nakae A, Stephens MJ, Rank M, D'Amico J, Harvey PJ, Li X, Harris RL, Ballou EW, Anelli R, Heckman CJ, Mashimo T, Vavrek R, Sanelli L, Gorassini MA, Bennett DJ, Fouad K. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat Med 16: 694-700, 2010.
33. 93ALow mice. J Neurophysiol 102: 3627-3642, 2009.
34. Pieri M, Carunchio I, Curcio L, Mercuri NB, Zona C. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 215: 368-379, 2009.
35. Ptak K, Zummo GG, Alheid GF, Tkatch T, Surmeier DJ, McCrimmon DR. Sodium currents in medullary neurons isolated from the pre-Botzinger complex region. J Neurosci 25: 5159-5170, 2005.
36. Quinlan K, Schuster J, Fu R, Siddique T, Heckman C. Altered postnatal maturation of electrical properties in spinal motoneurons in an ALS mouse model. J Physiol 589: 2245-2260, 2011.
37. Ramakers GJ, Boer GJ. Chronic suppression of bioelectric activity and cell survival in primary cultures of rat cerebral cortex: biochemical observations. Eur J Neurosci 3: 154-161, 1991.
38. Rank MM, Li X, Bennett DJ, Gorassini MA. Role of endogenous release of norepinephrine in muscle spasms after chronic spinal cord injury. J Neurophysiol 97: 3166-3180, 2007.
39. Rank MM, Murray KC, Stephens MJ, D'Amico J, Gorassini MA, Bennett DJ. Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury. J Neurophysiol 105: 410-422, 2011.
40. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van Den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
41. Ruijter JM, Baker RE, De Jong BM, Romijn HJ. Chronic blockade of bioelectric activity in neonatal rat cortex grown in vitro: morphological effects. Int J Dev Neurosci 9: 331-338, 1991.
42. Schonfeld-Dado E, Fishbein I, Segal M. Degeneration of cultured cortical neurons following prolonged inactivation: molecular mechanisms. J Neuro-chem 110: 1203-1213, 2009.
43. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996-2000. J Neurol 250: 473-479, 2003.
44. Turrigiano G, LeMasson G, Marder E. Selective regulation of current densities underlies spontaneous changes in the activity of cultured neurons. J Neurosci 15: 3640-3652, 1995.
45. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391: 892-896, 1998.
46. Urbani A, Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12: 3567-3574, 2000.
47. Van Damme P, Dewil M, Robberecht W, Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener Dis 2: 147-159, 2005.
48. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762: 1068-1082, 2006.
49. van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr, Constantine-Paton M, Bellingham MC. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28: 10864-10874, 2008.
50. Waibel S, Reuter A, Malessa S, Blaugrund E, Ludolph AC. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 251: 1080-1084, 2004.
51. Wu N, Enomoto A, Tanaka S, Hsiao CF, Nykamp DQ, Izhikevich E, Chandler SH. Persistent sodium currents in mesencephalic V neurons participate in burst generation and control of membrane excitability. J Neurophysiol 93: 2710-2722, 2004.
52. Zhong G, Masino MA, Harris-Warrick RM. Persistent sodium currents participate in fictive locomotion generation in neonatal mouse spinal cord. J Neurosci 27: 4507-4518, 2007.